Zhejiang University School of Medicine Researcher Discusses Research in Liver Cancer (Adjuvant TACE plus lenvatinib as compared with TACE alone in patients with hepatocellular carcinoma at high risk of recurrence after surgery: A prospective ...)

  • Bin Zhang

    Press/Media: Press / Media

    PeriodFeb 7 2024

    Media coverage

    1

    Media coverage

    • TitleZhejiang University School of Medicine Researcher Discusses Research in Liver Cancer (Adjuvant TACE plus lenvatinib as compared with TACE alone in patients with hepatocellular carcinoma at high risk of recurrence after surgery: A prospective ...)
      Media name/outletDisease Prevention Daily
      Country/TerritoryUnited States
      Date02/7/24
      PersonsBin Zhang
    View all 1
    View less